Alejo Rodriguez-Vida Selected Research

Alejo Rodriguez-Vida Research Topics

Disease

22	Neoplasms (Cancer) 04/2024 - 10/2015
18	Carcinoma (Carcinomatosis) 12/2023 - 11/2017
14	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 03/2014
6	Disease Progression 12/2023 - 10/2015
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 12/2013
5	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2021
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2019
2	Sepsis (Septicemia) 01/2021 - 11/2017
2	Fatigue 01/2021 - 01/2021
1	Melanoma (Melanoma, Malignant) 01/2024
1	Bone Resorption 10/2023
1	Kidney Neoplasms (Kidney Cancer) 10/2023
1	Uveal melanoma 01/2023
1	Myocardial Infarction 01/2021
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2021
1	Heart Failure 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Colitis 01/2021
1	Calcinosis Cutis 03/2020
1	Circulating Neoplastic Cells 01/2020
1	Neutropenia 01/2020
1	Febrile Neutropenia 01/2020
1	Lymphatic Metastasis 10/2015
1	Pneumonia (Pneumonitis) 03/2014

Drug/Important Bio-Agent (IBA)

12	Immune Checkpoint InhibitorsIBA 02/2023 - 12/2018
11	Biomarkers (Surrogate Marker)IBA 01/2024 - 03/2014
7	Docetaxel (Taxotere)FDA Link 03/2024 - 03/2014
7	atezolizumabIBA 12/2023 - 11/2019
7	PlatinumIBA 10/2023 - 10/2015
5	enzalutamideIBA 01/2022 - 03/2014
4	AndrogensIBA 03/2024 - 01/2022
4	Hormones (Hormone)IBA 03/2024 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2019
3	B7-H1 AntigenIBA 10/2023 - 01/2021
3	avelumabIBA 10/2023 - 01/2018
3	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 01/2021
3	Androgen Receptors (Androgen Receptor)IBA 09/2022 - 01/2019
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2023
2	apalutamideIBA 12/2023 - 01/2022
2	TOR Serine-Threonine KinasesIBA 11/2020 - 03/2014
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020 - 11/2017
2	RamucirumabIBA 01/2020 - 11/2017
2	abirateroneIBA 01/2019 - 03/2014
1	infigratinibIBA 04/2024
1	Androgen Antagonists (Antiandrogens)IBA 03/2024
1	cemiplimabIBA 01/2024
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2024
1	AfatinibIBA 12/2023
1	RadiumIBA 10/2023
1	Collagen Type I (Type I Collagen)IBA 10/2023
1	Alkaline PhosphataseIBA 10/2023
1	Radium-223IBA 10/2023
1	pyridinolineIBA 10/2023
1	durvalumabIBA 10/2023
1	4-1BB Ligand (4 1BB Ligand)IBA 10/2023
1	thiaclopridIBA 10/2023
1	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 10/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Messenger RNA (mRNA)IBA 09/2022
1	Therapeutic UsesIBA 09/2022
1	Axitinib (AG 013736)IBA 01/2022
1	darolutamideIBA 01/2022
1	Gemcitabine FDA Link 01/2021
1	AlbuminsIBA 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	pembrolizumabIBA 01/2021
1	Everolimus FDA Link 11/2020
1	Sunitinib (Sutent)FDA Link 11/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2020
1	Phosphates (Orthophosphate)IBA 03/2020
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 03/2020
1	Taxoids (Taxanes)IBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 11/2019
1	Galectins (Galectin)IBA 01/2019
1	sapanisertibIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	taxaneIBA 01/2019
1	serabelisibIBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	CytokinesIBA 01/2016
1	AZD4547IBA 10/2015
1	LigandsIBA 10/2015

Therapy/Procedure

17	Therapeutics 03/2024 - 03/2014
13	Castration 03/2024 - 11/2014
9	Drug Therapy (Chemotherapy) 12/2023 - 10/2015
5	Immunotherapy 01/2022 - 01/2016
3	Cystectomy 01/2022 - 11/2019
2	Radiotherapy 11/2022 - 12/2018
1	Intravenous Infusions 12/2023
1	Aftercare (After-Treatment) 11/2019
1	Precision Medicine 11/2014
1	Nephrectomy 03/2014
1	Metastasectomy 12/2013